When.com Web Search

  1. Ads

    related to: copd exacerbation treatment guidelines

Search results

  1. Results From The WOW.Com Content Network
  2. Acute exacerbation of chronic obstructive pulmonary disease

    en.wikipedia.org/wiki/Acute_exacerbation_of...

    The definition of a COPD exacerbation is commonly described as "lost in translation", [9] meaning that there is no universally accepted standard with regard to defining an acute exacerbation of COPD. Many organizations consider it a priority to create such a standard, as it would be a major step forward in the diagnosis and quality of treatment ...

  3. Global Initiative for Chronic Obstructive Lung Disease

    en.wikipedia.org/wiki/Global_Initiative_for...

    [1] [2] They have organized the annual awareness day, World COPD Day, every November since 2002. [ 3 ] This organization issues recommendations for the treatment of chronic obstructive pulmonary disease and related medical conditions.

  4. Chronic obstructive pulmonary disease - Wikipedia

    en.wikipedia.org/wiki/Chronic_obstructive...

    Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production or exacerbations) due to abnormalities of the airways (bronchitis ...

  5. Obstructive lung disease - Wikipedia

    en.wikipedia.org/wiki/Obstructive_lung_disease

    COPD is defined as a forced expiratory volume in 1 second divided by the forced vital capacity (FEV1/FVC) that is less than 0.7 (or 70%). [8] The residual volume, the volume of air left in the lungs following full expiration, is often increased in COPD, as is the total lung capacity, while the vital capacity remains relatively normal.

  6. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/...

    The combination fluticasone furoate/umeclidinium bromide/vilanterol product is approved by the US Food and Drug Administration with an indication for the maintenance treatment of a chronic lung problem called chronic obstructive pulmonary disease (COPD) in adults who (1) have already tried fluticasone furoate/vilanterol (brand name Breo Ellipta) but are still experiencing symptoms of airway ...

  7. Asthma-COPD overlap - Wikipedia

    en.wikipedia.org/wiki/Asthma-COPD_overlap

    ACO presents with symptoms of both asthma and COPD. [1] ACO presents in adulthood, usually after the age of 40 (after there has been significant tobacco smoke or other toxic fumes exposure), with symptoms of dyspnea (shortness of breath), exercise intolerance, sputum production, cough and episodes of symptomatic worsening known as exacerbations.